ClinVar Miner

Submissions for variant NM_000277.3(PAH):c.934G>C (p.Gly312Arg)

dbSNP: rs763115697
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen PAH Variant Curation Expert Panel RCV000758102 SCV000886575 uncertain significance Phenylketonuria 2018-12-09 reviewed by expert panel curation The c.934G>C (p.Gly312Arg) variant in PAH is absent from population databases, and predicted damaging by in silico algorithms. It is identified in a single patient with phenylketonuria, in trans with a VUS (IVS8-7A>G) Defect in BH4 metabolism was not excluded in this publication (Bashyam, 2014. PMID: 24130151). In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PP4, PM2, PP3.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003387922 SCV004100044 uncertain significance not specified 2023-09-21 criteria provided, single submitter clinical testing Variant summary: PAH c.934G>C (p.Gly312Arg) results in a non-conservative amino acid change located in the Aromatic amino acid hydroxylase, C-terminal domain (IPR019774) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251274 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.934G>C has been reported in the literature in at-least one individual affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria) (example: Bashyam_2014). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 24130151). Other variants affecting the same residue (p.Gly312Val, p.Gly312Cys, p.Gly312Asp) have been classified pathogenic or likely pathogenic in ClinVar (CV IDs 1458264, 446506, 102901). One submitter (ClinGen PAH Variant Curation Expert Panel) has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.